RT Journal Article
SR Electronic
T1 Virus strain of a mild COVID-19 patient in Hangzhou representing a new trend in SARS-CoV-2 evolution related to Furin cleavage site
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.10.20033944
DO 10.1101/2020.03.10.20033944
A1 Jin, Xi
A1 Xu, Kangli
A1 Jiang, Penglei
A1 Lian, Jiangshan
A1 Hao, Shaorui
A1 Jia, Hongyu
A1 Yao, Hangping
A1 Zhang, Yimin
A1 Zheng, Ruoheng
A1 Chen, Dong
A1 Yao, Jinmei
A1 Hu, Jianhua
A1 Gao, Jianguo
A1 Shen, Jian
A1 Wen, Liang
A1 Ren, Yue
A1 Yu, Guodong
A1 Wang, Xiaoyan
A1 Lu, Yingfeng
A1 Yu, Xiaopeng
A1 Yu, Liang
A1 Xiang, Dairong
A1 Zheng, Lin
A1 Wu, Nanping
A1 Lu, Xiangyun
A1 Cheng, Linfang
A1 Liu, Fumin
A1 Wu, Haibo
A1 Jin, Changzhong
A1 Yang, Xiaofeng
A1 Qian, Pengxu
A1 Qiu, Yunqing
A1 Sheng, Jifang
A1 Liang, Tingbo
A1 Li, Lanjuan
A1 Yang, Yida
YR 2020
UL http://medrxiv.org/content/early/2020/03/13/2020.03.10.20033944.abstract
AB We found, in our 788 confirmed COVID-19 patients, the decreased rate of severe/critical type, increased liver/kidney damage and prolonged period of nuclear acid positivity during virus dissemination, when compared with Wuhan. To investigate the underlining mechanism, we isolated one strain of SARS-CoV-2 (ZJ01) in mild COVID-19 patient and found the existence of 35 specific gene mutation by gene alignment. Further phylogenetic analysis and RSCU heat map results suggested that ZJ01 may be a potential evolutionary branch of SARS-CoV-2. We classified 54 strains of viruses worldwide (C/T type) based on the base (C or T) at positions 8824 and 28247. ZJ01 were both T at these two sites, becoming the only TT type currently identified in the world. The prediction of Furin cleavage site (FCS) and the sequence alignment of virus family indicated that FCS may be an important site of coronavirus evolution. ZJ01 had mutations near FCS (F1-2), which caused changes in the structure and the electrostatic distribution of the S protein surface, further affecting the binding capacity of Furin. Single cell sequencing and ACE2-Furin co-expression results confirmed that Furin level was higher in the whole body, especially in glands, liver, kidney and colon while FCS may help SARS-CoV-2 infect these organs. The evolutionary pattern of SARS-CoV-2 towards FCS formation may result in its clinical symptom becoming closer to HKU-1 and OC43 (the source of FCS sequence-PRRA) caused influenza, further showing potential in differentiating into mild COVID-19 subtypes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the National Key Program for Infectious Diseases of China (2017ZX10202202), the National Natural Science Foundation of China (No. 81770574, 81870080), the National Key R&D Program of China, Stem Cell and Translation Research (2018YFA0109300) and Zhejiang Province Science Foundation for Distinguished Young Scholars (LR19H080001)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnyone can share this material, provided it remains unaltered in any way, this is not done for commercial purposes, and the original authors are credited and cited.